BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21504283)

  • 1. Recurrence of cutaneous malignant melanoma after more than 20 years.
    Bredgaard R; Lock-Andersen J
    J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival with regional and distant metastases from cutaneous malignant melanoma.
    Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
    Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late recurrence of malignant tumours 20 years after diagnosis and treatment].
    Chodorowski Z; Sein Anand J; Jassem J; Kopacz A; Kruszewski W; Emerich J; Senkus-Konefka E
    Przegl Lek; 2007; 64(4-5):372-3. PubMed ID: 17724919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late recurrence of melanoma beyond 10 years].
    Avril MF; Nguyen T; Duvillard P; Bognel C; Margulis A
    Ann Dermatol Venereol; 1994; 121(6-7):454-8. PubMed ID: 7702277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of patients with recurrence of primary melanoma at least 10 years following surgical treatment].
    Klaase JM; Kroon BB
    Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2488-91. PubMed ID: 7800074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-late recurrence (15 years or longer) of cutaneous melanoma.
    Tsao H; Cosimi AB; Sober AJ
    Cancer; 1997 Jun; 79(12):2361-70. PubMed ID: 9191524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE; Selim MA; Mosca PJ; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg Oncol; 2006 May; 13(5):728-39. PubMed ID: 16538415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
    Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.
    McCarthy WH; Shaw HM; Thompson JF; Milton GW
    Surg Gynecol Obstet; 1988 Jun; 166(6):497-502. PubMed ID: 3375961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can late recurrence of melanoma be predicted at the time of primary treatment.
    Khanna AK; Laidler P; Hughes LE
    Eur J Surg Oncol; 1986 Mar; 12(1):9-12. PubMed ID: 3956758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.